A nomogram for preoperative prediction of microvascular invasion in ruptured hepatocellular carcinoma. Issue 5 (13th May 2023)

• Record Type: Journal Article
• Authors: Xia, Feng; Zhang, Qiao; Ndhlovu, Elijah; Zheng, Jun; Gao, Hengyi; Xia, Guobing
• Is Part Of: European journal of gastroenterology & hepatology. Volume 35:Issue 5(2023)
• Page Start: 591
• Page End: 599
• Publication Date: 2023-05-13
• Subjects: microvascular invasion -- nomogram -- predictive model -- ruptured hepatocellular carcinoma; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Digestive organs -- Diseases; Liver -- Diseases; Periodicals; 616.33
• DOI: 10.1097/MEG.0000000000002535
• Languages: English
• ISSNs: 0954-691X

Abstract

Abstract : Background and aim: Microvascular invasion (MVI) is defined as the presence of micrometastatic cancer cell emboli in hepatic vessels, including small vessels, and at present, researchers believe that is an important factor for early postoperative recurrence and survival. Here, we developed and validated a preoperative predictive model for the presence of MVI in patients with ruptured hepatocellular carcinoma (rHCC). Methods: We retrospectively collected data for 210 rHCC patients who underwent staged hepatectomy at Wuhan Tongji Hospital, and 91 patients who underwent staged hepatectomy at Zhongshan People's Hospital between January 2010 and March 2021. Then, the former was used as the training cohort and the latter was used as the validation cohort. Logistic regression was used to screen for variables associated with MVI, and these variables were used to construct nomograms. We used R software to assess the discrimination, calibration ability, as well as clinical efficacy of nomograms. Results: Multivariate logistic regression analysis identified four risk factors independently associated with MVI: max tumor length [odds ratio (OR) = 1.385; 95% confidence interval (CI), 1.072–1.790], number of tumors (OR = 2.182; 95% CI, 1.129–5.546), direct bilirubin (OR = 1.515; 95% CI, 1.189–1.930), and alpha-fetoprotein (cutoff = 400 ng/mL) (OR = 2.689; 95% CI, 3.395–13.547). Nomograms were built from the four variables and they were tested for discrimination and calibration, and the results were good. Conclusion: We developed and validated a preoperative predictive model for the presence of MVI in patients with ruptured HCC. This model can help clinicians identify patients at risk of MVI and make better treatment options.